US approves new HBV drug.
Bernard
Edwin J
EJ
D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D010919:Placebos; D014481:United States; D014486:United States Food and Drug Administration; D019562:Viral Load
D000998:Antiviral Agents; D010919:Placebos; C413685:entecavir; D006147:Guanine